| Financial Year |
March 31 2023 |
| Monetary Funds |
564,375,490.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
28,493,753.40 |
| Advances to Suppliers |
11,763,321.85 |
| Other Receivables |
14,203,461.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
67,197,393.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,607,545.23 |
| Total Current Assets |
730,640,966.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,507,385.05 |
| Investment Properties |
-- |
| Fixed Assetes |
73,448,109.64 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,950,826.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,965,613.33 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
110,209,048.20 |
| Total Assets |
840,850,014.89 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
12,084,772.68 |
| Accounts Received In Advance |
20,129.99 |
| Employee Compensation Payable |
9,627,269.01 |
| Taxes Payable |
9,335,329.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
170,549,129.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,057,068.81 |
| Other Current Liabilities |
211,182.82 |
| Sub-Total of Current Liabilities |
206,522,723.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
2,278,032.42 |
| Sub-Total of Non-Current Liabilities |
8,962,091.09 |
| Total Liabilities |
215,484,814.99 |
| Paid-In Capital(Or Share Stock) |
1,311,254,521.00 |
| Capital Surplus |
2,041,253,974.32 |
| Surplus Reserve |
29,332,370.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,766,226,955.43 |
| Minority Stockholder's Interest |
9,751,289.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
615,613,910.47 |
| Owner's Equity（Stockholder's Equity） |
625,365,199.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
840,850,014.89 |
